greeksoup/ stock research

Addus HomeCare Corp.: Q2 FY2026 earnings call

What management said about Q2 FY2026, from the documents filed with the SEC on 3 August 2026: press release. The quarter’s numbers.

Key takeaways

  • Net revenues grew 8.0% to $377.4 million: Net service revenues reached $377.4 million, up 8.0% from $349.4 million year-over-year. Organic growth by segment: personal care 6.8%, hospice 11.1%, home health -2.8%. Six-month revenues increased 7.8% to $741.0 million from $687.2 million. Source
  • Net income increased 25.2% to $27.6 million: Net income was $27.6 million, or $1.49 per diluted share, compared with $22.1 million, or $1.20 per share, in Q2 2025. For six months, net income increased to $52.7 million, or $2.85 per share, from $43.3 million. Source
  • Adjusted EBITDA increased 11.9% to $49.2 million: Adjusted EBITDA was $49.2 million, up 11.9% from $43.9 million in Q2 2025. Six-month adjusted EBITDA increased 10.9% to $93.7 million. Adjusted net income per diluted share increased 16.1% to $1.73 from $1.49. Source
  • Personal care generated $296 million, 78.4% of revenue: Personal care revenues were $296.0 million, accounting for 78.4% of total revenues, with 6.8% organic growth. Same-store billable census of 49,955 reflected higher volumes. Including acquisitions, average billable census was 51,097, up from 50,404 prior year. Source
  • Hospice organic revenue growth accelerated to 11.1%: Hospice revenues were $64.2 million, representing 17.0% of total revenues, with 11.1% organic growth in Q2 2026, up from 7.7% in Q1 2026. Growth was driven by improvements in average daily census and revenue per patient day. Source
  • Operating cash flow doubled to $40.0 million: Net cash provided by operating activities was $40.0 million in Q2 2026, up 77.6% from $22.5 million in Q2 2025. Six-month operating cash flow was $92.4 million, more than doubling from $41.5 million in the prior year period. Source
  • Bank debt reduced 61.9% to $64.3 million: Bank debt declined significantly to $64.3 million from $169.1 million in Q2 2025. Cash position of $99.6 million maintained. Improved leverage ratio provides financial flexibility to pursue targeted acquisitions and strategic investments throughout 2026. Source

“We are extremely pleased with the strong financial and operational performance delivered in the second quarter of 2026. Revenues grew by 8.0%, driven by solid organic growth and disciplined execution across our service lines. Our focus on cost management, operational efficiency, and leverage reduction translated into an 11.9% improvement in adjusted EBITDA and a 25.2% increase in net income over the second quarter last year”

Dirk Allison, Chairman and Chief Executive Officer

What changed from last quarter

  • New: HomeCourt Home Care acquisition closed May 1 and contributed two months of operations to Q2 results, with approximately 240 clients and annualized revenues of $9.7 million. Source
  • Guidance kept: Second Indiana personal care acquisition remains pending with expected close later in 2026; no update on timing in Q2.

Second Quarter Revenue and Earnings

  • Net revenues grew 8.0% to $377.4 million: Net service revenues reached $377.4 million, up 8.0% from $349.4 million year-over-year. Organic growth by segment: personal care 6.8%, hospice 11.1%, home health -2.8%. Six-month revenues increased 7.8% to $741.0 million from $687.2 million. Source
  • Net income increased 25.2% to $27.6 million: Net income was $27.6 million, or $1.49 per diluted share, compared with $22.1 million, or $1.20 per share, in Q2 2025. For six months, net income increased to $52.7 million, or $2.85 per share, from $43.3 million. Source
  • Adjusted EBITDA increased 11.9% to $49.2 million: Adjusted EBITDA was $49.2 million, up 11.9% from $43.9 million in Q2 2025. Six-month adjusted EBITDA increased 10.9% to $93.7 million. Adjusted net income per diluted share increased 16.1% to $1.73 from $1.49. Source

Personal Care Segment Performance

  • Personal care generated $296 million, 78.4% of revenue: Personal care revenues were $296.0 million, accounting for 78.4% of total revenues, with 6.8% organic growth. Same-store billable census of 49,955 reflected higher volumes. Including acquisitions, average billable census was 51,097, up from 50,404 prior year. Source

“Our strong performance in the first half of 2026 positions us well moving forward. We generated meaningful operating cash flow and maintained a very strong balance sheet. Our low leverage allows us to invest strategically and continue to pursue targeted acquisitions”

Dirk Allison, Chairman and Chief Executive Officer

Hospice Segment Strong Growth

  • Hospice organic revenue growth accelerated to 11.1%: Hospice revenues were $64.2 million, representing 17.0% of total revenues, with 11.1% organic growth in Q2 2026, up from 7.7% in Q1 2026. Growth was driven by improvements in average daily census and revenue per patient day. Source
  • Average daily census increased 6.5% to 3,964: Hospice average daily census increased 6.5% to 3,964 patients from 3,720 in Q2 2025. Revenue per patient day improved to $190.66 from $184.92. Average discharge length of stay increased to 100.1 days from 90.6 days, reflecting patient acuity. Source

Home Health and Care Continuum

  • Home health revenues declined organically 2.8%: Home health revenues were $17.2 million, representing 4.6% of total revenues. Organic revenue decline of 2.8% improved from Q1's -6.6% decline. New admissions increased 9.8% to 5,016, indicating improving patient flow and admission trends. Source
  • Management emphasizes full continuum care model: Management views home health as providing important complementary clinical capabilities for the full continuum of care in select markets, allowing more patients to receive all three levels of care within the Addus platform. Source

Operating Cash Flow and Balance Sheet

  • Operating cash flow doubled to $40.0 million: Net cash provided by operating activities was $40.0 million in Q2 2026, up 77.6% from $22.5 million in Q2 2025. Six-month operating cash flow was $92.4 million, more than doubling from $41.5 million in the prior year period. Source
  • Bank debt reduced 61.9% to $64.3 million: Bank debt declined significantly to $64.3 million from $169.1 million in Q2 2025. Cash position of $99.6 million maintained. Improved leverage ratio provides financial flexibility to pursue targeted acquisitions and strategic investments throughout 2026. Source
  • Revolving credit facility provides $577.8 million liquidity: Company maintains revolving credit capacity of $650.0 million with $577.8 million available for borrowing. Strong balance sheet and low leverage position enable management to pursue targeted acquisition opportunities and strategic investments. Source

Acquisitions and Strategic Expansion

  • HomeCourt acquisition contributed two months of results: HomeCourt Home Care acquisition closed May 1, 2026, contributing two months of operations in Q2. Acquisition serves approximately 240 clients with annualized revenues of approximately $9.7 million and was expected to be immediately accretive to financial results. Source
  • Additional Indiana acquisition expected to close in 2026: Company entered definitive agreement for additional Indiana personal care acquisition of similar size to HomeCourt. Expected to close later in 2026. Acquisition strategy focused on expanding geographic reach, increasing market density, and building scale in selected states.
  • Disciplined approach to clinical and non-clinical acquisitions: Management emphasizes disciplined evaluation of clinical and non-clinical acquisition opportunities to enhance market density and geographic reach. By delivering full continuum of care and scaling operations, company anticipates realizing meaningful synergies and growth opportunities. Source

Coming up, as management said on 3 August 2026

  • Additional Indiana acquisition expected to close: Company signed definitive agreement for second Indiana personal care acquisition of similar size to HomeCourt. Expected to close later in 2026 to further expand geographic reach and market density in the state.

Earlier plans management reported on

  • Met: HomeCourt closed May 1 and contributed two months of operations in Q2 2026, contributing to revenue and earnings growth.
  • Not stated: Company entered definitive agreement in Q1 for second Indiana acquisition. No update on closing timeline provided in Q2 earnings.

Other quarters

Summarised with AI from the documents the company filed with the SEC. Every point is checked against the filing before it is shown: management’s own words word for word, figures against the line or table row they come from. A point that fails the check is left out. Source opens the filing at that line.